These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12468923)

  • 1. Recombinant plasminogen activator therapy for cerebral vein thrombosis in a child carrier of prothrombin gene mutation.
    Tarani L; Iacobini M; De Stefano V; Smacchia MP; Tozzi MC; Raguso G; Bruni L
    J Pediatr Hematol Oncol; 2002 Dec; 24(9):769-71. PubMed ID: 12468923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cerebral venous thrombosis in a girl carrier of the prothrombin gene mutation 20210G--> A treated by local fibrinolysis of the superior sagittal sinus].
    Perez- Dueñas B; Cambra- Lasaosa FJ; Noguera-Julián A; Palomeque-Rico A; Toll-Costa T; Campistol J; Guimaraens-Martínez L; Vivas-Díaz E
    Rev Neurol; 2002 Nov 16-30; 35(10):913-7. PubMed ID: 12436395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cerebral venous thrombosis associated to subacute De Quervain's thyroiditis in a carrier for the G20210A mutation of the prothrombin gene].
    Madroñero-Vuelta AB; Sanahuja-Montesinos J; Bergua-Llop M; Araguás-Arasanz C
    Rev Neurol; 2004 Sep 16-30; 39(6):533-5. PubMed ID: 15467991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe venous thrombosis in an infant heterozygous for the G20210A mutation in the prothrombin gene.
    Martínez-Tallo E; Alonso N; Campo-Sampedro F; Agulla E; Hernandez-Rastrollo R; Galán E
    Acta Paediatr; 2003 Sep; 92(9):1111-3. PubMed ID: 14599081
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
    Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral venous thrombosis and familial prothrombin gene G20210a mutation].
    Verdelho A; Ferro JM; Palmeiro A; Antunes C
    Rev Neurol; 2001 Aug 16-31; 33(4):335-8. PubMed ID: 11588727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis.
    Gonzalez JV; Barboza AG; Vazquez FJ; Gándara E
    PLoS One; 2016; 11(3):e0151607. PubMed ID: 27031503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral vein thrombosis and prothrombin gene (G20210A) mutation.
    Heckmann JG; Tomandl B; Erbguth F; Neidhardt B; Zingsem H; Neundörfer B
    Clin Neurol Neurosurg; 2001 Oct; 103(3):191-3. PubMed ID: 11532562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsurgical repair after crush-avulsion injury of the femoral vein in rats: prevention of microvascular thrombosis with recombinant human tissue-type plasminogen activator (rt-PA).
    Lykoudis EG; Contodimos GB; Tsoutsos DA; Frangia KB; Papalois AE; Stamatopoulos CN; Ioannovich JD
    Microsurgery; 2001; 21(8):357-61. PubMed ID: 11757061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful recanalization of late portal vein thrombosis after liver transplantation using systemic low-dose recombinant tissue plasminogen activator.
    Guckelberger O; Bechstein WO; Langrehr JM; Kratschmer B; Loeffel J; Settmacher U; Neuhaus R; Lopez Haenninen E; Venz S; Vogl TJ; Neuhaus P
    Transpl Int; 1999; 12(4):273-7. PubMed ID: 10460873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.
    Röttger C; Madlener K; Heil M; Gerriets T; Walberer M; Wessels T; Bachmann G; Kaps M; Stolz E
    Stroke; 2005 Apr; 36(4):841-6. PubMed ID: 15731475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial thrombus in a 10-month-old boy--successful thrombolysis with recombinant tissue-type plasminogen activator after open-heart surgery: review of the literature.
    Kehl HG; Kececioglu D; Vielhaber H; Kotthoff S; Weyand M; Jorch G; Vogt J; Nowak-Göttl U
    Intensive Care Med; 1996 Sep; 22(9):968-71. PubMed ID: 8905435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review.
    Viegas LD; Stolz E; Canhão P; Ferro JM
    Cerebrovasc Dis; 2014; 37(1):43-50. PubMed ID: 24356180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of severe sinus vein thrombosis with super selective thrombolysis in a pre-adolescent with diabetic ketoacidosis and a prothrombin gene mutation.
    Zerah M; Patterson R; Hansen I; Briones M; Dion J; Renfroe B
    J Pediatr Endocrinol Metab; 2007 Jun; 20(6):725-31. PubMed ID: 17663298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis.
    Grunwald MR; Hofmann LV
    J Vasc Interv Radiol; 2004 Apr; 15(4):347-52. PubMed ID: 15064337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy.
    Goldhaber SZ
    Adv Intern Med; 1999; 44():311-25. PubMed ID: 9929714
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of recombinant tissue plasminogen activator for venous thrombosis after paediatric heart surgery.
    Justice LB; Nelson DP; Palumbo J; Sawyer J; Patel MN; Byrnes JW
    Cardiol Young; 2018 Feb; 28(2):214-221. PubMed ID: 28889818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.